CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
5 Considerations for Scaling-Up PSC-Derived Cell Therapies
21 Nov 2019

What Are the Benefits of an Automated High-Throughput Screening Process for Custom Cell Culture Media Development?

We are often asked if culture media development can be customized at t...

01 Sep 2019

What are the Key Benefits of Chemically Defined (CD) and Animal Component Free (ACF) Media?

New cell and gene therapies are rapidly being translated into the clin...

Tell us what you thought about this post.